Unlimited License: An Analysis of the Canadian Biotechnology Advisory Committee’s Report on Patenting Higher Life Forms

Our publications are available to all at no cost. Please support the CCPA and help make important research and ideas available to everyone. Make a donation today.

Donate
  • Biotechnology
    Health Care
    Reports

    Unlimited License

    Public debates over controversial biotechnologies often revolve around questions about who will control them and what values will guide their development. Because patent policies shape…

Updates from the CCPA

Read the latest research, analysis and commentary on issues that matter to you.

CCPA Updates